Transmissible spongiform encephalopathy

Jump to navigation Jump to search

Transmissible spongiform encephalopathy Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Transmissible spongiform encephalopathy from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Neurocognitive Disorder Due to Prion Disease

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Transmissible spongiform encephalopathy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Transmissible spongiform encephalopathy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Transmissible spongiform encephalopathy

CDC on Transmissible spongiform encephalopathy

Transmissible spongiform encephalopathy in the news

Blogs on Transmissible spongiform encephalopathy

Directions to Hospitals Treating Transmissible spongiform encephalopathy

Risk calculators and risk factors for Transmissible spongiform encephalopathy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Kiran Singh, M.D. [2] Rinky Agnes Botleroo, M.B.B.S.

For patient information, click here

Synonyms and keywords: TSE; prion diseases

Overview

Historical Perspective

  • Natural Scrapie is a infection that affects sheep and is caused by an unusual infectious agent.It was first described in 1732.
  • Kuru is the first prion disease in humans which was described in 1957.It is a fatal exotic neurodegenerative disease that affects only people of a single language group in the remote mountainous interior of New Guinea.
  • In 1959, veterinary pathologist W.J. Hadlow first recognized several similarities between Scrapie and Kuru, which is a fatal exotic neurodegenerative disease that affects only people of a single language group in the remote mountainous interior of New Guinea.
  • In 1959, I. Klatzo also noted that Kuru's histopathology resembled that of Creutzfeldt-Jakob disease (CJD), another fatal neurodegenerative progressive disease of unknown etiology that A.M. Jakob had first described in 1921.
  • Gajdusek, C.J. Gibbs, Jr., and M.P. Alpers used the existing knowledge of Scrapie and started efforts to transmit Kuru by inoculating Kuru brain tissue into non-human primates, that-although requiring several years-ultimately proved successful in 1965.Later Gajdusek and colleagues went on to demonstrate that not only the more common sporadic form of CJD but also familial CJD and a generally similar familial brain disease (Gerstmann-Sträussler-Scheinker syndrome) were also transmissible, first to non-human primates and later to other animals.
  • In 1982, Stanley B. Prusiner formulated "prion hypothesis". Prusiner recognized that a misfolded form of a ubiquitous normal host protein was usually (if not always) detectable in tissues containing TSE agents, greatly facilitating the diagnosis and understanding their pathogenesis. Prusiner proposed that the TSE agent was likely to be composed partly (if not entirely )of the abnormal protein, for which he used the term "prion" protein and "prion" for the agent. Expression of the prion protein by animals-while not essential for life-was later found to be obligatory to infect them with TSEs

Pathophysiology

Causes

Differentiating Transmissible spongiform encephalopathy from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Major or Mild Neurocognitive Disorder Due to Prion Disease

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Primary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1

References

  • This entry incorporates public domain text originally from the National Institute of Neurological Disorders and Stroke, National Institutes of Health [3] and the U.S. National Library of Medicine [4]
  • Brown P, Preece M, Brandel JP, Sato T, McShane L, Zerr I, Fletcher A, Will RG, Pocchiari M, Cashman NR, d'Aignaux JH, Cervenakova L, Fradkin J, Schonberger LB, Collins SJ (2000). "Iatrogenic Creutzfeldt-Jakob disease at the millennium". Neurology. 55 (8): 1075–81. PMID 11071481.
  • Montagna P, Gambetti P, Cortelli P, Lugaresi E (2003). "Familial and sporadic fatal insomnia". Lancet Neurol. 2 (3): 167–76. PMID 12849238.
  • Prusiner SB (2001). "Shattuck lecture--neurodegenerative diseases and prions". N Engl J Med. 344 (20): 1516–26. PMID 11357156.
  • Weissmann C (2004). "The state of the prion". Nat Rev Microbiol. 2 (11): 861–71. PMID 15494743.

External Links

Template:Prion diseases

cs:Transmisivní spongiformní encefalopatie da:TSE de:Transmissible spongiforme Enzephalopathie ko:프리온 질병 simple:Prion disease

Template:WH Template:WS